Means to improve cognition in healthy elderly and patients with mild cognitive impairment – from training to non-invasive brain stimulation - Combination therapy of tACS and cognitive training for the treatment of MCI

niversitätsmedizin Göttingen0 个研究点目标入组 77 人开始时间: 2021年5月10日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Mild cognitive impairment (MCI) or cognitive ability in the context of healthy aging.
•2. The ability to voluntarily give consent to participate in the study.

•1. Pacemakers, deep brain stimulation
•2. Intracerebral metal implants (e.g. clips after surgery of an intracerebral aneurysms, implantation of an artificial cochlea)
•3. Evidence of epileptic seizures or stroke in the medical history.
•4. Age < 55 or > 85 years.
•5. Craniocerebral trauma with loss of consciousness in the previous history
•6. Presence of a serious internal or neurological disease (e.g. untreated tumors, cancer)
•7. Serious neurological or psychiatric diseases (except MCI) (schizophrenia, Parkinson's disease, multiple sclerosis, severe depression)
•8. Glaucoma, retinitis pigmentosa
•9. blood pressure > 160/100 Hgmm
•10. OPs within the last three months
•11. Chemotherapy within the last 12 months
•12. Alcohol, medicine and drug addiction
•13. Receptive or global aphasia (disturbance of speech understanding or additionally of speaking)
•14. Drugs at the time of inclusion (Neuroleptics, Benzodiazepines, Antiepileptic drugs)
•15. Participation in another clinical trial within the last 8 weeks

发起方

niversitätsmedizin Göttingen